What does ICARIS mean?
ICARIS means Intervention Cardiology Risk Stratification
What is the abbreviation for Intervention Cardiology Risk Stratification?
Intervention Cardiology Risk Stratification can be abbreviated as ICARIS
|
|
Most popular questions people look for before coming to this page
Q: A: |
What does ICARIS stand for? ICARIS stands for "Intervention Cardiology Risk Stratification". |
Q: A: |
How to abbreviate "Intervention Cardiology Risk Stratification"? "Intervention Cardiology Risk Stratification" can be abbreviated as ICARIS. |
Q: A: |
What is the meaning of ICARIS abbreviation? The meaning of ICARIS abbreviation is "Intervention Cardiology Risk Stratification". |
Q: A: |
What is ICARIS abbreviation? One of the definitions of ICARIS is "Intervention Cardiology Risk Stratification". |
Q: A: |
What does ICARIS mean? ICARIS as abbreviation means "Intervention Cardiology Risk Stratification". |
Q: A: |
What is shorthand of Intervention Cardiology Risk Stratification? The most common shorthand of "Intervention Cardiology Risk Stratification" is ICARIS. |
Abbreviations or Slang with similar meaning
- MBRST - Modified Binary Risk Stratification Tool
- STROLS - Stratification On Line System
- CCND - Cardiology Consultants of North Dallas
- CAK - Cardiology Associates of Kentucky
- CITY - Cardiology in the Young
- CMS - Cardiology Monitoring System
- CPACS - Cardiology Picture Archiving and Communication System
- CTAO - Cardiology Technologists Association of Ontario
- CTABC - Cardiology Technologists Association of British Columbia
- NERS - New Risk Stratification
- CAA - Cardiology Advocacy Alliance
- CaCC - Cardiology Associates of Corpus Christi
- CAFC - Cardiology Associates of Fairfield County
- RRSS - Registry and Risk Stratification System
- SMDR - Stratification and Migration Dynamics in Russia
- SSIFT - Stratification and Synchronization Inference Technology
- RIS - Risk Intervention Study
- RISK - Risk Intervention Skills Study
- ssm - Stratification and Social Mobility
- ACES - Cardiology Azithromycin Coronary Events Study A trial that asked whether Chlamydia pneumoniae infection is causally associated with cardiovascular disease and, if so, whether azithromycin treatment would reduce the risk of subsequent coronary events